Search research articles
Contact Us
Filters
Showing results (31-40 of 54) with videos related to
Page
of 6
Sort By:
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
February 27, 2010
Comparative expression of a set of genes to an internal housekeeping control in CDNA amplified and not amplified by PolyAPCR in non-Hodgkin's lymphoma samples obtained from fine-needle aspiration cytology
Fernanda Cristina Corbi, Riguel Jun Inaoka, Roberta Spetic Felix, et al.
Biochemical and Biophysical Research Communications
|
September 22, 2019
Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines
Rebecca S S Barbosa, Paola M Dantonio, Taís Guimarães, et al.
Leukemia & Lymphoma
|
December 25, 2003
Importance of combined-modality therapy for primary bone lymphoma
O C G Baiocchi, G W B Colleoni, C A Rodrigues, et al.
Leukemia & Lymphoma
|
May 27, 2004
Possible influence of clinical stage and type of treatment in the persistence of residual circulating t(14;18)-positive cells in follicular lymphoma patients
Gisele W B Colleoni, Luiz Cláudio C Duarte, Fábio R Kerbauy, et al.
Leukemia & Lymphoma
|
June 10, 2010
Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy
Valéria C C Andrade, André L Vettore, Rodrigo A Panepucci, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 10, 2002
Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma
Otavio C G Baiocchi, Gisele W B Colleoni, Eduardo V Navajas, et al.
Leukemia & Lymphoma
|
February 13, 2013
Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant
Rodrigo C Fernando, Edgar G Rizzatti, Walter M T Braga, et al.
Plos One
|
November 24, 2011
Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines
Fabricio de Carvalho, Erico T Costa, Anamaria A Camargo, et al.
Leukemia & Lymphoma
|
July 16, 2005
Epstein-Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: a nested case-control study in a renal transplant cohort
Otávio C G Baiocchi, Gisele W B Colleoni, Otávia L Caballero, et al.
Cancer Immunology, Immunotherapy : CII
|
May 29, 2012
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients
Riguel J Inaoka, Achim A Jungbluth, Sacha Gnjatic, et al.
Page
of 6
Search research articles
Search
Showing results (31-40 of 54) with videos related to
Sort By:
Page
of 6
Diagnostic Molecular Pathology : the American Journal of Surgical Pathology, Part B
|
February 27, 2010
Comparative expression of a set of genes to an internal housekeeping control in CDNA amplified and not amplified by PolyAPCR in non-Hodgkin's lymphoma samples obtained from fine-needle aspiration cytology
Fernanda Cristina Corbi, Riguel Jun Inaoka, Roberta Spetic Felix, et al.
Biochemical and Biophysical Research Communications
|
September 22, 2019
Sequential combination of bortezomib and WEE1 inhibitor, MK-1775, induced apoptosis in multiple myeloma cell lines
Rebecca S S Barbosa, Paola M Dantonio, Taís Guimarães, et al.
Leukemia & Lymphoma
|
December 25, 2003
Importance of combined-modality therapy for primary bone lymphoma
O C G Baiocchi, G W B Colleoni, C A Rodrigues, et al.
Leukemia & Lymphoma
|
May 27, 2004
Possible influence of clinical stage and type of treatment in the persistence of residual circulating t(14;18)-positive cells in follicular lymphoma patients
Gisele W B Colleoni, Luiz Cláudio C Duarte, Fábio R Kerbauy, et al.
Leukemia & Lymphoma
|
June 10, 2010
Number of expressed cancer/testis antigens identifies focal adhesion pathway genes as possible targets for multiple myeloma therapy
Valéria C C Andrade, André L Vettore, Rodrigo A Panepucci, et al.
Acta Oncologica (Stockholm, Sweden)
|
July 10, 2002
Impact of highly active antiretroviral therapy in the treatment of HIV-infected patients with systemic non-Hodgkin's lymphoma
Otavio C G Baiocchi, Gisele W B Colleoni, Eduardo V Navajas, et al.
Leukemia & Lymphoma
|
February 13, 2013
Serum free light chains and post-transplant lymphoproliferative disorder in patients with renal transplant
Rodrigo C Fernando, Edgar G Rizzatti, Walter M T Braga, et al.
Plos One
|
November 24, 2011
Targeting MAGE-C1/CT7 expression increases cell sensitivity to the proteasome inhibitor bortezomib in multiple myeloma cell lines
Fabricio de Carvalho, Erico T Costa, Anamaria A Camargo, et al.
Leukemia & Lymphoma
|
July 16, 2005
Epstein-Barr viral load, interleukin-6 and interleukin-10 levels in post-transplant lymphoproliferative disease: a nested case-control study in a renal transplant cohort
Otávio C G Baiocchi, Gisele W B Colleoni, Otávia L Caballero, et al.
Cancer Immunology, Immunotherapy : CII
|
May 29, 2012
Cancer/testis antigens expression and autologous serological response in a set of Brazilian non-Hodgkin's lymphoma patients
Riguel J Inaoka, Achim A Jungbluth, Sacha Gnjatic, et al.
Page
of 6